Provider
Somatostatin Analogs - Commercial
Prior Authorization, Quantity Limit
Program effective Date: Mar 01, 2026
Search Results
Displaying 4151 - 4160 of 4182 results
Provider
Thrombopoietin Receptor Agonists, Tavalisse, and Wayrilz - Commercial
Prior Authorization, Quantity Limit
Program effective Date: Mar 01, 2026
Provider
High Cost Agents - Commercial
Prior Authorization
Program effective Date: Mar 01, 2026
Provider
Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) - Commercial
Prior Authorization, Quantity Limit
Program effective Date: Mar 01, 2026
Provider
Elmiron - Commercial
Prior Authorization, Quantity Limit
Program effective Date: Mar 01, 2026
Provider
Efgartigimod - Commercial
Prior Authorization, Quantity Limit
Program effective Date: Mar 01, 2026
Provider
Interleukin-13 (IL-13) Antagonist - Medicaid
Prior Authorization, Quantity Limit
Program effective Date: Mar 01, 2026
Provider
Interleukin-31 (IL-31) Inhibitor - Medicaid
Prior Authorization, Quantity Limit
Program effective Date: Mar 01, 2026
Provider
Buprenorphine, Buprenorphine/Naloxone for Opioid Dependence - Commercial
Quantity Limit
Program effective Date: Mar 01, 2026
Provider
Cibinqo (abrocitinib) - Commercial
Prior Authorization, Quantity Limit
Program effective Date: Mar 01, 2026